Mutations or deletions in the NOD2 gene can promote the reverse transport of slgA and increase the sIgA–pathogen complex through M cells into intestine-associated lymphoid tissues, leading to the worsening of IBD (125). Here, NOD2 is linked to inflammatory bowel disease.